IBDEI0MM ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10165,1,4,0)
;;=4^E10.3211
;;^UTILITY(U,$J,358.3,10165,2)
;;=^5138279
;;^UTILITY(U,$J,358.3,10166,0)
;;=E10.3212^^39^430^20
;;^UTILITY(U,$J,358.3,10166,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10166,1,3,0)
;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
;;^UTILITY(U,$J,358.3,10166,1,4,0)
;;=4^E10.3212
;;^UTILITY(U,$J,358.3,10166,2)
;;=^5138280
;;^UTILITY(U,$J,358.3,10167,0)
;;=E10.3213^^39^430^21
;;^UTILITY(U,$J,358.3,10167,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10167,1,3,0)
;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
;;^UTILITY(U,$J,358.3,10167,1,4,0)
;;=4^E10.3213
;;^UTILITY(U,$J,358.3,10167,2)
;;=^5138281
;;^UTILITY(U,$J,358.3,10168,0)
;;=E10.39^^39^430^26
;;^UTILITY(U,$J,358.3,10168,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10168,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Ophth Compl
;;^UTILITY(U,$J,358.3,10168,1,4,0)
;;=4^E10.39
;;^UTILITY(U,$J,358.3,10168,2)
;;=^5002603
;;^UTILITY(U,$J,358.3,10169,0)
;;=E10.40^^39^430^10
;;^UTILITY(U,$J,358.3,10169,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10169,1,3,0)
;;=3^DM Type 1 w/ Diab Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,10169,1,4,0)
;;=4^E10.40
;;^UTILITY(U,$J,358.3,10169,2)
;;=^5002604
;;^UTILITY(U,$J,358.3,10170,0)
;;=E10.41^^39^430^7
;;^UTILITY(U,$J,358.3,10170,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10170,1,3,0)
;;=3^DM Type 1 w/ Diab Mononeuropathy
;;^UTILITY(U,$J,358.3,10170,1,4,0)
;;=4^E10.41
;;^UTILITY(U,$J,358.3,10170,2)
;;=^5002605
;;^UTILITY(U,$J,358.3,10171,0)
;;=E10.42^^39^430^11
;;^UTILITY(U,$J,358.3,10171,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10171,1,3,0)
;;=3^DM Type 1 w/ Diab Polyneuropathy
;;^UTILITY(U,$J,358.3,10171,1,4,0)
;;=4^E10.42
;;^UTILITY(U,$J,358.3,10171,2)
;;=^5002606
;;^UTILITY(U,$J,358.3,10172,0)
;;=E10.43^^39^430^2
;;^UTILITY(U,$J,358.3,10172,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10172,1,3,0)
;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,10172,1,4,0)
;;=4^E10.43
;;^UTILITY(U,$J,358.3,10172,2)
;;=^5002607
;;^UTILITY(U,$J,358.3,10173,0)
;;=E10.44^^39^430^1
;;^UTILITY(U,$J,358.3,10173,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10173,1,3,0)
;;=3^DM Type 1 w/ Diab Amyotrophy
;;^UTILITY(U,$J,358.3,10173,1,4,0)
;;=4^E10.44
;;^UTILITY(U,$J,358.3,10173,2)
;;=^5002608
;;^UTILITY(U,$J,358.3,10174,0)
;;=E10.49^^39^430^25
;;^UTILITY(U,$J,358.3,10174,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10174,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Neurological Compl
;;^UTILITY(U,$J,358.3,10174,1,4,0)
;;=4^E10.49
;;^UTILITY(U,$J,358.3,10174,2)
;;=^5002609
;;^UTILITY(U,$J,358.3,10175,0)
;;=E10.59^^39^430^22
;;^UTILITY(U,$J,358.3,10175,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10175,1,3,0)
;;=3^DM Type 1 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,10175,1,4,0)
;;=4^E10.59
;;^UTILITY(U,$J,358.3,10175,2)
;;=^5002612
;;^UTILITY(U,$J,358.3,10176,0)
;;=E10.610^^39^430^9
;;^UTILITY(U,$J,358.3,10176,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10176,1,3,0)
;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,10176,1,4,0)
;;=4^E10.610
;;^UTILITY(U,$J,358.3,10176,2)
;;=^5002613
;;^UTILITY(U,$J,358.3,10177,0)
;;=E10.618^^39^430^23
;;^UTILITY(U,$J,358.3,10177,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10177,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Arthropathy
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0MM 3754 printed Apr 09, 2024@21:17:26 Page 2
IBDEI0MM ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10165,1,4,0)
+2 ;;=4^E10.3211
+3 ;;^UTILITY(U,$J,358.3,10165,2)
+4 ;;=^5138279
+5 ;;^UTILITY(U,$J,358.3,10166,0)
+6 ;;=E10.3212^^39^430^20
+7 ;;^UTILITY(U,$J,358.3,10166,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,10166,1,3,0)
+10 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
+11 ;;^UTILITY(U,$J,358.3,10166,1,4,0)
+12 ;;=4^E10.3212
+13 ;;^UTILITY(U,$J,358.3,10166,2)
+14 ;;=^5138280
+15 ;;^UTILITY(U,$J,358.3,10167,0)
+16 ;;=E10.3213^^39^430^21
+17 ;;^UTILITY(U,$J,358.3,10167,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,10167,1,3,0)
+20 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
+21 ;;^UTILITY(U,$J,358.3,10167,1,4,0)
+22 ;;=4^E10.3213
+23 ;;^UTILITY(U,$J,358.3,10167,2)
+24 ;;=^5138281
+25 ;;^UTILITY(U,$J,358.3,10168,0)
+26 ;;=E10.39^^39^430^26
+27 ;;^UTILITY(U,$J,358.3,10168,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,10168,1,3,0)
+30 ;;=3^DM Type 1 w/ Oth Diab Ophth Compl
+31 ;;^UTILITY(U,$J,358.3,10168,1,4,0)
+32 ;;=4^E10.39
+33 ;;^UTILITY(U,$J,358.3,10168,2)
+34 ;;=^5002603
+35 ;;^UTILITY(U,$J,358.3,10169,0)
+36 ;;=E10.40^^39^430^10
+37 ;;^UTILITY(U,$J,358.3,10169,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,10169,1,3,0)
+40 ;;=3^DM Type 1 w/ Diab Neuropathy,Unspec
+41 ;;^UTILITY(U,$J,358.3,10169,1,4,0)
+42 ;;=4^E10.40
+43 ;;^UTILITY(U,$J,358.3,10169,2)
+44 ;;=^5002604
+45 ;;^UTILITY(U,$J,358.3,10170,0)
+46 ;;=E10.41^^39^430^7
+47 ;;^UTILITY(U,$J,358.3,10170,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,10170,1,3,0)
+50 ;;=3^DM Type 1 w/ Diab Mononeuropathy
+51 ;;^UTILITY(U,$J,358.3,10170,1,4,0)
+52 ;;=4^E10.41
+53 ;;^UTILITY(U,$J,358.3,10170,2)
+54 ;;=^5002605
+55 ;;^UTILITY(U,$J,358.3,10171,0)
+56 ;;=E10.42^^39^430^11
+57 ;;^UTILITY(U,$J,358.3,10171,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,10171,1,3,0)
+60 ;;=3^DM Type 1 w/ Diab Polyneuropathy
+61 ;;^UTILITY(U,$J,358.3,10171,1,4,0)
+62 ;;=4^E10.42
+63 ;;^UTILITY(U,$J,358.3,10171,2)
+64 ;;=^5002606
+65 ;;^UTILITY(U,$J,358.3,10172,0)
+66 ;;=E10.43^^39^430^2
+67 ;;^UTILITY(U,$J,358.3,10172,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,10172,1,3,0)
+70 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
+71 ;;^UTILITY(U,$J,358.3,10172,1,4,0)
+72 ;;=4^E10.43
+73 ;;^UTILITY(U,$J,358.3,10172,2)
+74 ;;=^5002607
+75 ;;^UTILITY(U,$J,358.3,10173,0)
+76 ;;=E10.44^^39^430^1
+77 ;;^UTILITY(U,$J,358.3,10173,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,10173,1,3,0)
+80 ;;=3^DM Type 1 w/ Diab Amyotrophy
+81 ;;^UTILITY(U,$J,358.3,10173,1,4,0)
+82 ;;=4^E10.44
+83 ;;^UTILITY(U,$J,358.3,10173,2)
+84 ;;=^5002608
+85 ;;^UTILITY(U,$J,358.3,10174,0)
+86 ;;=E10.49^^39^430^25
+87 ;;^UTILITY(U,$J,358.3,10174,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,10174,1,3,0)
+90 ;;=3^DM Type 1 w/ Oth Diab Neurological Compl
+91 ;;^UTILITY(U,$J,358.3,10174,1,4,0)
+92 ;;=4^E10.49
+93 ;;^UTILITY(U,$J,358.3,10174,2)
+94 ;;=^5002609
+95 ;;^UTILITY(U,$J,358.3,10175,0)
+96 ;;=E10.59^^39^430^22
+97 ;;^UTILITY(U,$J,358.3,10175,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,10175,1,3,0)
+100 ;;=3^DM Type 1 w/ Oth Circulatory Compl
+101 ;;^UTILITY(U,$J,358.3,10175,1,4,0)
+102 ;;=4^E10.59
+103 ;;^UTILITY(U,$J,358.3,10175,2)
+104 ;;=^5002612
+105 ;;^UTILITY(U,$J,358.3,10176,0)
+106 ;;=E10.610^^39^430^9
+107 ;;^UTILITY(U,$J,358.3,10176,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,10176,1,3,0)
+110 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
+111 ;;^UTILITY(U,$J,358.3,10176,1,4,0)
+112 ;;=4^E10.610
+113 ;;^UTILITY(U,$J,358.3,10176,2)
+114 ;;=^5002613
+115 ;;^UTILITY(U,$J,358.3,10177,0)
+116 ;;=E10.618^^39^430^23
+117 ;;^UTILITY(U,$J,358.3,10177,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,10177,1,3,0)
+120 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
